Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Feb 17, 2021

30016_dirs_2021-02-17_435beb35-5bab-448a-a53e-7fc65ccb435c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14

Reporting Person: TWIGGE GIOVANI (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-14 Common Stock M 405 Acquired 13340 Direct
2021-02-14 Common Stock M 212 Acquired 13552 Direct
2021-02-14 Common Stock M 168 Acquired 13720 Direct
2021-02-14 Common Stock M 157 Acquired 13877 Direct
2021-02-14 Common Stock M 184 Acquired 14061 Direct
2021-02-14 Common Stock F 338 $544.08 Disposed 13723 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-14 Non-Qualified Stock Option (right-to-buy) $544.08 A 4236 Acquired 2031-02-13 Common Stock (4236) Direct
2021-02-14 Incentive Stock Option (right-to-buy) $544.08 A 183 Acquired 2031-02-13 Common Stock (183) Direct
2021-02-14 Restricted Stock Unit $ A 459 Acquired Common Stock (459) Direct
2021-02-14 Restricted Stock Unit $ M 405 Disposed Common Stock (405) Direct
2021-02-14 Restricted Stock Unit $ M 212 Disposed Common Stock (212) Direct
2021-02-14 Restricted Stock Unit $ M 168 Disposed Common Stock (168) Direct
2021-02-14 Restricted Stock Unit $ M 157 Disposed Common Stock (157) Direct
2021-02-14 Restricted Stock Unit $ M 184 Disposed Common Stock (184) Direct

Footnotes

F1: Includes 13 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.

F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F11: Not applicable.